Yeo TP, Hruban RH, Leach SD, Wilentz RE, Sohn TA, Kern SE, Iacobuzio-Donahue CA, Maitra A, Goggins M, Canto MI: Pancreatic cancer. Curr Probl Cancer. 2002, 26 (4): 176-275.
Article
PubMed
Google Scholar
Schleger C, Verbeke C, Hildenbrand R, Zentgraf H, Bleyl U: c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance. Mod Pathol. 2002, 15 (4): 462-469.
Article
CAS
PubMed
Google Scholar
Mahlamaki EH, Barlund M, Tanner M, Gorunova L, Hoglund M, Karhu R, Kallioniemi A: Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer. 2002, 35 (4): 353-358.
Article
CAS
PubMed
Google Scholar
Yamada H, Sakamoto H, Taira M, Nishimura S, Shimosato Y, Terada M, Sugimura T: Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes. Jpn J Cancer Res. 1986, 77 (4): 370-375.
CAS
PubMed
Google Scholar
Sandgren EP, Quaife CJ, Paulovich AG, Palmiter RD, Brinster RL: Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc Natl Acad Sci USA. 1991, 88 (1): 93-97.
Article
PubMed Central
CAS
PubMed
Google Scholar
Liao DJ, Wang Y, Wu J, Adsay NV, Grignon D, Khanani F, Sarkar FH: Characterization of pancreatic lesions from MT-tgfalpha, Ela-myc and MT-tgfalpha/Ela-myc single and double transgenic mice. J Carcinog. 2006, 5: 19-
Article
PubMed Central
PubMed
Google Scholar
Liao JD, Adsay NV, Khannani F, Grignon D, Thakur A, Sarkar FH: Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancer. Histol Histopathol. 2007, 22 (6): 661-676.
PubMed Central
CAS
PubMed
Google Scholar
Keleg S, Buchler P, Ludwig R, Buchler MW, Friess H: Invasion and metastasis in pancreatic cancer. Mol Cancer. 2003, 2: 14-
Article
PubMed Central
PubMed
Google Scholar
Kleeff J, Friess H, Berberat PO, Martignoni ME, Z'Graggen K, Buchler MW: Pancreatic cancer – new aspects of molecular biology research. Swiss Surg. 2000, 6 (5): 231-234.
Article
CAS
PubMed
Google Scholar
Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R: Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol. 2003, 162 (4): 1151-1162.
Article
PubMed Central
CAS
PubMed
Google Scholar
Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, van Heek T, Ashfaq R, Meyer R, Walter K, Berg K, Hollingsworth MA, Cameron JL: Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol. 2002, 160 (4): 1239-1249.
Article
PubMed Central
CAS
PubMed
Google Scholar
Maacke H, Jost K, Opitz S, Miska S, Yuan Y, Hasselbach L, Luttges J, Kalthoff H, Sturzbecher HW: DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. Oncogene. 2000, 19 (23): 2791-2795.
Article
CAS
PubMed
Google Scholar
Lynch HT, Deters CA, Snyder CL, Lynch JF, Villeneuve P, Silberstein J, Martin H, Narod SA, Brand RE: BRCA1 and pancreatic cancer: pedigree findings and their causal relationships. Cancer Genet Cytogenet. 2005, 158 (2): 119-125.
Article
CAS
PubMed
Google Scholar
Mahlamaki EH, Kauraniemi P, Monni O, Wolf M, Hautaniemi S, Kallioniemi A: High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer. Neoplasia. 2004, 6 (5): 432-439.
Article
PubMed Central
CAS
PubMed
Google Scholar
Nakamura T, Fidler IJ, Coombes KR: Gene expression profile of metastatic human pancreatic cancer cells depends on the organ microenvironment. Cancer Res. 2007, 67 (1): 139-148.
Article
CAS
PubMed
Google Scholar
Nakamura T, Furukawa Y, Nakagawa H, Tsunoda T, Ohigashi H, Murata K, Ishikawa O, Ohgaki K, Kashimura N, Miyamoto M: Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene. 2004, 23 (13): 2385-2400.
Article
CAS
PubMed
Google Scholar
Soling A, Sackewitz M, Volkmar M, Schaarschmidt D, Jacob R, Holzhausen HJ, Rainov NG: Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma. Clin Cancer Res. 2005, 11 (1): 249-258.
PubMed
Google Scholar
Sanada Y, Oue N, Mitani Y, Yoshida K, Nakayama H, Yasui W: Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J Pathol. 2006, 208 (5): 633-642.
Article
CAS
PubMed
Google Scholar
Yonezawa S, Byrd JC, Dahiya R, Ho JJ, Gum JR, Griffiths B, Swallow DM, Kim YS: Differential mucin gene expression in human pancreatic and colon cancer cells. Biochem J. 1991, 276 (Pt 3): 599-605.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hollingsworth MA, Swanson BJ: Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer. 2004, 4 (1): 45-60.
Article
CAS
PubMed
Google Scholar
Resar LM, Dolde C, Barrett JF, Dang CV: B-myc inhibits neoplastic transformation and transcriptional activation by c-myc. Mol Cell Biol. 1993, 13 (2): 1130-1136.
PubMed Central
CAS
PubMed
Google Scholar
Griffith OL, Melck A, Jones SJ, Wiseman SM: Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J Clin Oncol. 2006, 24 (31): 5043-5051.
Article
CAS
PubMed
Google Scholar
Moore LE, Fung ET, McGuire M, Rabkin CC, Molinaro A, Wang Z, Zhang F, Wang J, Yip C, Meng XY: Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population. Cancer Epidemiol Biomarkers Prev. 2006, 15 (9): 1641-1646.
Article
CAS
PubMed
Google Scholar
Weinstein PS, Skinner M, Sipe JD, Lokich JJ, Zamcheck N, Cohen AS: Acute-phase proteins or tumour markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases. Scand J Immunol. 1984, 19 (3): 193-198.
Article
CAS
PubMed
Google Scholar
Sato N, Fukushima N, Maitra A, Iacobuzio-Donahue CA, van Heek NT, Cameron JL, Yeo CJ, Hruban RH, Goggins M: Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Pathol. 2004, 164 (3): 903-914.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lian Z, De Luca P, Di Cristofano A: Gene expression analysis reveals a signature of estrogen receptor activation upon loss of Pten in a mouse model of endometrial cancer. J Cell Physiol. 2006, 208 (2): 255-266.
Article
CAS
PubMed
Google Scholar
Liu AY, Zhang H, Sorensen CM, Diamond DL: Analysis of prostate cancer by proteomics using tissue specimens. J Urol. 2005, 173 (1): 73-78.
Article
CAS
PubMed
Google Scholar
Mauri P, Scarpa A, Nascimbeni AC, Benazzi L, Parmagnani E, Mafficini A, Della Peruta M, Bassi C, Miyazaki K, Sorio C: Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. Faseb J. 2005, 19 (9): 1125-1127.
CAS
PubMed
Google Scholar
Hansel DE, Rahman A, House M, Ashfaq R, Berg K, Yeo CJ, Maitra A: Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms. Clin Cancer Res. 2004, 10 (18 Pt 1): 6152-6158.
Article
CAS
PubMed
Google Scholar
Karna E, Surazynski A, Orlowski K, Laszkiewicz J, Puchalski Z, Nawrat P, Palka J: Serum and tissue level of insulin-like growth factor-I (IGF-I) and IGF-I binding proteins as an index of pancreatitis and pancreatic cancer. Int J Exp Pathol. 2002, 83 (5): 239-245.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zumkeller W: IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?. Mol Pathol. 2001, 54 (5): 285-288.
Article
PubMed Central
CAS
PubMed
Google Scholar
Yamada S, Ohira M, Horie H, Ando K, Takayasu H, Suzuki Y, Sugano S, Hirata T, Goto T, Matsunaga T: Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas. Oncogene. 2004, 23 (35): 5901-5911.
Article
CAS
PubMed
Google Scholar
Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD: Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science. 2003, 302 (5653): 2141-2144.
Article
CAS
PubMed
Google Scholar
Pajares MJ, Ezponda T, Catena R, Calvo A, Pio R, Montuenga LM: Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol. 2007, 8 (4): 349-357.
Article
CAS
PubMed
Google Scholar
Srebrow A, Kornblihtt AR: The connection between splicing and cancer. J Cell Sci. 2006, 119 (Pt 13): 2635-2641.
Article
CAS
PubMed
Google Scholar
Venables JP: Aberrant and alternative splicing in cancer. Cancer Res. 2004, 64 (21): 7647-7654.
Article
CAS
PubMed
Google Scholar
Brinkman BM: Splice variants as cancer biomarkers. Clin Biochem. 2004, 37 (7): 584-594.
Article
CAS
PubMed
Google Scholar
Hayes GM, Carrigan PE, Beck AM, Miller LJ: Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma. Cancer Res. 2006, 66 (7): 3819-3827.
Article
CAS
PubMed
Google Scholar
Zahler AM, Neugebauer KM, Lane WS, Roth MB: Distinct functions of SR proteins in alternative pre-mRNA splicing. Science. 1993, 260 (5105): 219-222.
Article
CAS
PubMed
Google Scholar
Stickeler E, Kittrell F, Medina D, Berget SM: Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene. 1999, 18 (24): 3574-3582.
Article
CAS
PubMed
Google Scholar
Bailis JM, Forsburg SL: MCM proteins: DNA damage, mutagenesis and repair. Curr Opin Genet Dev. 2004, 14 (1): 17-21.
Article
CAS
PubMed
Google Scholar
Hirano T: At the heart of the chromosome: SMC proteins in action. Nat Rev Mol Cell Biol. 2006, 7 (5): 311-322.
Article
CAS
PubMed
Google Scholar
Amor DJ, Kalitsis P, Sumer H, Choo KH: Building the centromere: from foundation proteins to 3D organization. Trends Cell Biol. 2004, 14 (7): 359-368.
Article
CAS
PubMed
Google Scholar
Khanna KK, Jackson SP: DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet. 2001, 27 (3): 247-254.
Article
CAS
PubMed
Google Scholar
Kataoka H, Itoh H, Koono M: Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration. Pathol Int. 2002, 52 (2): 89-102.
Article
CAS
PubMed
Google Scholar
Firth SM, Baxter RC: Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 2002, 23 (6): 824-854.
Article
CAS
PubMed
Google Scholar
Perks CM, Newcomb PV, Norman MR, Holly JM: Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells. J Mol Endocrinol. 1999, 22 (2): 141-150.
Article
CAS
PubMed
Google Scholar
Jones JI, Doerr ME, Clemmons DR: Cell migration: interactions among integrins, IGFs and IGFBPs. Prog Growth Factor Res. 1995, 6 (2–4): 319-327.
Article
CAS
PubMed
Google Scholar
Petrache I, Fijalkowska I, Zhen L, Medler TR, Brown E, Cruz P, Choe KH, Taraseviciene-Stewart L, Scerbavicius R, Shapiro L: A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema. Am J Respir Crit Care Med. 2006, 173 (11): 1222-1228.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zelvyte I, Wallmark A, Piitulainen E, Westin U, Janciauskiene S: Increased plasma levels of serine proteinase inhibitors in lung cancer patients. Anticancer Res. 2004, 24 (1): 241-247.
CAS
PubMed
Google Scholar
Trichopoulos D, Tzonou A, Kalapothaki V, Sparos L, Kremastinou T, Skoutari M: Alpha 1-antitrypsin and survival in pancreatic cancer. Int J Cancer. 1990, 45 (4): 685-686.
Article
CAS
PubMed
Google Scholar
Tzonou A, Sparos L, Kalapothaki V, Zavitsanos X, Rebelakos A, Trichopoulos D: Alpha 1-antitrypsin and survival in hepatocellular carcinoma. Br J Cancer. 1990, 61 (1): 72-73.
Article
PubMed Central
CAS
PubMed
Google Scholar
Higashiyama M, Doi O, Kodama K, Yokouchi H, Tateishi R: An evaluation of the prognostic significance of alpha-1-antitrypsin expression in adenocarcinomas of the lung: an immunohistochemical analysis. Br J Cancer. 1992, 65 (2): 300-302.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sun Z, Yang P: Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. Lancet Oncol. 2004, 5 (3): 182-190.
Article
CAS
PubMed
Google Scholar
Higashiyama M, Doi O, Kodama K, Yokouchi H, Tateishi R, Matsuura N, Murata A, Tomita N, Monden T, Ogawa M: Immunohistochemical analysis of pancreatic secretory trypsin inhibitor expression in pulmonary adenocarcinoma: its possible participation in scar formation of the tumor tissues. Tumour Biol. 1992, 13 (5–6): 299-307.
Article
CAS
PubMed
Google Scholar
Thakur A, Xu H, Wang Y, Bollig A, Biliran H, Liao JD: The role of X-linked genes in breast cancer. Breast Cancer Res Treat. 2005, 93 (2): 135-143.
Article
CAS
PubMed
Google Scholar
Oji Y, Nakamori S, Fujikawa M, Nakatsuka S, Yokota A, Tatsumi N, Abeno S, Ikeba A, Takashima S, Tsujie M: Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma. Cancer Sci. 2004, 95 (7): 583-7.
Article
CAS
PubMed
Google Scholar